Deudomperidone

氘代多潘立酮

Report date: 2025/02/28 11:25:39
NME

Base Information

Drug NameDeudomperidone
Drug Alias NameDeuterated domperidoneDomperidone deuteratedCIN-102
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionDopamine D2 receptor antagonistsDopamine D3 receptor antagonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsDiabetic GastroparesisGastroparesis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCinRx Pharma Llc
China Registration ClassN/A

Develop Information

Active CompaniesCindome Pharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetic GastroparesisGastroparesis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A